Wilma G.
- Country
- Germany
- Department
- NA
Research Overview
- Menthacarin® in the treatment of functional gastrointestinal disorders
- Evaluation of Budesonide, Glycopyrronium Bromide, and Formoterol Fumarate on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease Patients
- Evaluation of Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections
Data & Insights
Has run more than one trial at 239 of 806 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in heart failure management, particularly focusing on novel therapeutic combinations for patients with reduced ejection fraction. Their research extends to hypertriglyceridemia treatment, exploring innovative approaches to lipid management.
- Advanced heart failure therapies
- Lipid disorders
- Cardiovascular outcomes
Their work encompasses comprehensive cardiovascular risk management strategies.
Respiratory Medicine
The investigator conducts research in respiratory infectious diseases and chronic pulmonary conditions. Their expertise includes vaccine development for respiratory syncytial virus and management of COPD.
- RSV vaccination in older adults
- COPD treatment optimization
- Respiratory therapeutics
Their research addresses both preventive and therapeutic aspects of respiratory medicine.
Metabolic Disorders
The investigator focuses on complex metabolic conditions, including type 2 diabetes and obesity management. Their research explores innovative therapeutic approaches for weight management in metabolic disorders.
- Weight management therapies
- Diabetes treatment
- Metabolic syndrome
Their work integrates multiple approaches to metabolic health optimization.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.